BASILEA PHARMACEUTICA AG ALLSCHWIL revenue breakdown overview

BASILEA PHARMACEUTICA AG ALLSCHWIL revenue for the last year amounted to 187.19 M USD, the most of which — 187.23 M USD — came from its highest performing source at the moment, Innovative Pharmaceutical Products, the year earlier bringing 159.79 M USD. The greatest contribution to the revenue figure was made by Ireland — last year it brought BASILEA PHARMACEUTICA AG ALLSCHWIL 81.60 M USD, and the year before that — 44.66 M USD.